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ABSTRACT
Objective: To evaluate the effect of Chlamydia trachomatis infection during pregnancy on perinatal 
morbidity and mortality. Methods: Systematic review and meta-analysis in an electronic database 
and manual, combining high sensitivity specific descriptors seeking to answer the research objective. 
The articles considered to be of high methodological quality (score above 6 on the Newcastle-Ottawa 
Scale) were assessed by meta-analysis. Results: Summary estimates of 12 studies were calculated by 
means of Mantel-Haenszel test with 95% confidence interval. It was observed that Chlamydia infec-
tion during pregnancy increased risk of preterm labor (relative risk (RR) = 1.35 [1.11, 1.63]), low 
birth weight (RR = 1.52 [1.24, 1.87]) and perinatal mortality (RR = 1.84 [1.15, 2.94]). No evidence 
of increased risk was associated with Chlamydia infection in regard to premature rupture of mem-
branes (RR = 1.13 [0.95, 1.34]), abortion and postpartum endometritis (RR = 1.20 [0.65, 2.20] and 
0.89 [0.49, 1.61] respectively). Conclusion: The diagnosis and treatment of Chlamydia cervicitis dur-
ing pregnancy can reduce perinatal morbidity and mortality associated with this infection. However, 
clinical trials are needed to confirm these findings.
Keywords: Chlamydia trachomatis; perinatal mortality; morbidity; meta-analysis.
INTRODUCTION
Chlamydia trachomatis (CT) is responsible for 
the most prevalent sexually transmitted bacte-
rial infection worldwide.1-4 The World Health 
Organization (WHO) estimates that 92 mil-
lion new cases occur annually, four million in 
the United States and 10 million in Europe.1,3-5 
In Brazil an estimate from the Ministry of 
Health states approximately two million new 
cases only in 2001.6
Besides high prevalence, another concern 
is the high annual cost resulting from the se-
quels of this infection, estimated at four billion 
dollars, thus achieving second place among the 
most expensive sexually transmitted diseases 
(STDs).1,7 CT is usually asymptomatic and per-
sistent, as well as widely distributed throughout 
the population; especially among the young.8,9
On the other hand, in Brazil CT detection is 
not a routine procedure: it is only recommend-
ed when patients show symptoms. This lack of 
diagnosis contributes considerably to the high 
prevalence of untreated CT leading to seriously 
damaging consequences.10
In women CT initially infects the cervix and 
urethra, eventually causing abnormal vaginal 
discharge and dysuria. When not treated the 
infection can reach the fallopian tubes, causing 
pelvic inflammatory disease and adhesions.11-13 
Abdominal pain, back pain, nausea, fever, dys-
pareunia, or menorrhagia affect up to 40% of 
untreated women. The sequelae resulting from 
CT include chronic pelvic pain, infertility and 
increased incidence of ectopic pregnancy.14-16
In pregnant women, CT is even more 
critical as it may affect normal intra- and extra-
uterine development.17 The pregnancy itself 
seems to increase the risk of CT colonization 
and alter immune response. It may also in-
fluence the clinical manifestations of disease 
in pregnant women.18,19 In the United States, 
2% to 13.7% of pregnant women are carriers 
of CT.18-22 In Brazil some studies have shown 
prevalence rates of between 2.7% and 10%.2,10,23 
In this group, CT has been associated with an 
increased risk of preterm delivery, spontaneous 
abortion,24 low birth weight, premature rupture 
of membranes (PROM) and perinatal mortal-
ity.25,26 Moreover, children of mothers with CT Este é um artigo Open Access sob
 a licença de CC BY-NC-ND
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may be infected during passage through the birth canal, de-
veloping conjunctivitis and pneumonia.27
That being said, studies conducted in pregnant women 
infected with CT show conflicting results regarding the risk 
of these events. Knowledge concerning the impact of infec-
tion in this group can improve counseling and treatment of 
infected pregnant women as a public health measure.
The objective of this meta-analysis was to evaluate peri-
natal morbidity associated with CT infection, determining 
the risk of preterm labor (PTL), PROM, low birth weight, 
perinatal mortality, endometritis and abortion.
MATERIAL AND METHODS
Studies were selected through systematic review to de-
termine the risk of perinatal morbidity and mortality 
associated with CT infection, and classified according 
to the outcomes: PTL (labor occurring before 37 weeks 
gestation), PROM, low birth weight (full term new-
born weighing less than 2500 grams), perinatal mortal-
ity (mortality occurring between 20 weeks of gestation 
until 28 days after birth), endometritis (infection of the 
endometrium or decidua) and abortion (expulsion or 
fetal death before 20 weeks gestation). Searches were con-
ducted on electronic databases such as PubMed, Embase, 
Lilacs, Cochrane, and Google Scholar. Manual searches 
were also conducted through gynecology journals and 
the bibliographies of reviewed articles.
The first part of the study involved examining major 
electronic databases. Results were acquired searching by 
keyword and specific descriptors determined by the data-
base criteria, and combined to increase the sensitivity of 
the search for articles on the assessment of risk associated 
to CT infection in pregnancy (Box 1).
Articles were selected by means of eligibility criteria. 
To be included, a cohort study or case control study need-
ed to be carried out on pregnant women diagnosed with 
CT during pregnancy who underwent medical follow-up 
before and after childbirth. Publications from January 
1980 to January 2010 were considered in English, Por-
tuguese, Spanish or French. Articles were only included 
following the evaluation and agreement of two reviewers.
The Newcastle-Ottawascale was used to assess the 
methodological quality of studies. This scale varies 
between zero and nine points: studies with a score equal 
to or higher than six were considered methodologically 
sound.
Data collection of the primary studies was made 
using the appropriate instrument (the Newcastle scale) 
in order to obtain a summary measure flow chart. After 
calculating relative risk using the Mantel-Haenszel with a 
confidence interval of 95%, tabulation and interpretation 
of results ensued. 
RESULTS
After a manual search of the databases, 2695 articles were col-
lected. Of these, 2550 articles were excluded when the titles and 
abstracts were not found to meet eligibility criteria (Box 1).
Among the 145 remaining items, the 12 selected 
had a score equal to or greater than 6 on the Newcas-
tle-Ottawa scale (Table 1). The selected articles are risk 
assessment studies, carried out in populations of preg-
nant women who sought care in prenatal clinics at least 
until the end of the pregnancy. The diagnostic methods 
used included culture, molecular biology tests and/or 
IgM antibodies (Table 1). 
CT prevalence ranged from 2.4% to 35.9%, depending 
on the characteristics of the population studied and the di-
agnostic methods used (Table 1). It was observed that CT 
infection during pregnancy increased the risk of PTL 1.51 
[1.27, 1.80]. The test for heterogeneity was found to be sig-
nificant when all items were considered in the evaluation. 
The analysis of funnel plot items from Gravett et al.,28 Jain 
et al.29 and Martin et al.30 were removed for statistical re-
evaluation, and as a result the relative risk (RR) decreased 
to 1:35 [1.11, 1.63] while heterogeneity lost its significance 
(p = 0.07). (Table 2). The RR of CT infection and PROM 
was 1.13 [0.95 1:34] and the studies were found to be homo-
geneous for meta-analysis (heterogeneity p = 0.10). Similar 
results were found with low birth weight, RR = 1.52 [1.24, 1.87], 
among the studies considered homogeneous for evaluation 
(p = 0.1) (Table 2). Perinatal mortality was found to have a RR 
of 2.44 [1.63, 3.68], and items were shown to be heterogene-
ous (p = 0.02). Following the evaluation of the funnel plot, the 
studies by Jain et al.29 and Martin et al.30 were removed, since 
their RR was 1.84 [1.15, 2.94] p = 1.0. (Figure 1).
Regarding endometritis and abortion, no significant 
correlation with CT in pregnancy was found, RR = 1.20 
[0.65, 2.20] and RR = 0.89 [0.49, 1.61] respectively. Few 
studies of good quality have addressed such outcomes 
(Box 1).
Box 1: Article selection process from the search to the 
quality assessment.
2695 articles identified in electronic databases and 
manual search
2550 articles excluded after assessment of titles and 
abstracts
145 articles with full text assessment
77 excluded articles (did not present adequate study 
design – cohort or case control)
68 articles with full text assessment
56 excluded articles (did not meet the selection criteria)
13 articles
Loss =1
12 articles
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Table 1. Characteristics of risk assessment studies included in meta-analysis
Autor Design Local Exclusion criteria n Loss Time Diagnostic P (Chlamydia Newcastle- 
      (months) method  trachomatis) Ottawa  
        score 
Andrews Cohort EUA Pregnants  2570 214 12 LCR 9.9% (238:2398) 8 
et al.20 nested   (16 to 23)  
  trial   weeks
Berman  Retrospective India Pregnants  1203 104 36 Culture 22% (251/1152) 8 
et al.31 cohort  < 24 weeks
Blas Retrospective EUA Pregnants 4255 425* 12 PCR - 7 
et al.13 cohort 
Gravett  Prospective EUA Pregnants 582 28 5 Culture 9% (47/534) 6 
et al.28 cohort  2-3 trimester
Harrison Prospective EUA < 32 weeks 1365 180 18 Culture 8% ( 94 /1185) 7 
et al.32 cohort 
Jain Case-control  India Pregnants 78 18 3 IgM 35.9% (28/78) 6 
et al.29   3rd trimeste  
   to labor
Kirk Prospective London Pregnants  1101 295 4 Vaginal 2.2% (18/806) 6 
et al.17 cohort  < 14 weeks     PCR 
Kovacs Prospective Hungary Pregnants 6161  18 Gen  5.75% (362 /6161) 7 
et al.33 cohort      probe 
Martin Prospective EUA Pregnants 304 36 12 Culture 6.7% (18/268) 7 
et al.30 cohort  < 19 weeks
Oakeshott Prospective England Pregnants 1216 15 24 PCR 2.4% (19/1214) 7 
et al.34  cohort < 14 weeks
Silveira  Retrospective EUA Pregnants 2127 9 31 PCR 4.7% 6 
et al.35 cohort  > 20 weeks
Yu Prospective China Pregnants 300 0 10 PCR 11% (33/300) 7 
et al.36 cohort 
n, number of subjects; loss, loss to follow-up; P, prevalence.
* loss of approximately 10%.
DISCUSSION
CT genital infection is considered a potential risk factor 
for perinatal complications and has been the subject of 
numerous studies in recent decades. In this review, risk 
of PTL was found to be associated with CT infection, with 
a measure of RR of 1.51 [1.27, 1.80]. A more conservative 
assessment including only articles considered statistically 
homogeneous lowered the risk, RR = 1.35 [1.11, 1.63], 
even though this assessment showed the highest risk of 
PTL delivery for pregnant women infected with CT. Blas 
et al. study13 was significant to this review due to sample 
size and confirmed this association as also seen in smaller 
studies.20,28,30,32,35 Studies suggest that treatment of CT in-
fection reduces the morbidity of pregnancy. However data 
from Andrews et al.20 do not confirm this fact, suggesting 
that gestational age at treatment and re-infection may also 
influence perinatal morbidity.37
Similarly, PROM was also more common in pregnant 
women infected with CT, OR = 1.13 [0.95, 1.34]. However 
since the confidence interval includes the null value, the fact 
that CT infection increases the risk of PROM could not be 
confirmed. Kovacs et al. study,33 which was the most signifi-
cant among the included, showed no significant difference 
in the association between CT infection and PROM.13,28,33,36 
There is evidence that timely treatment of CT during ante-
natal care can significantly decrease the risk of PROM. That 
Silva, Florêncio, Gabiatti, et al.
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Table 2. Summary estimates of selected studies for association between Chlamydia infection and perinatal  
morbidity, according to the outcomes
2.1 Preterm labor
             Experimental  Control  Risk ratio  Risk ratio 
Study Events Total Events Total Weight M-H, fixed, 95% CI            M-H, fixed, 95% CI
Andrews et al.20 24 233 191 2123 25.3% 1.14 (0.77, 1.71)
Blas et al.13 76 735 181 2972 48.2% 1.70 (1.32, 2.19)  
Gravett et al.28 17 47 64 535 0.0% 3.02 (1.94, 4.71)  
Harrison et al.32 8 48 100 558 10.6% 0.93 (0.48, 1.79)  
Jain et al.32 2 21 0 39 0.0% 9.09 (0.46, 181.04)  
Martin et al.30 5 18 15 250 0.0% 4.63 (1.90, 11.30)  
Silveira et al.35 11 97 254 1988 15.9% 0.89 (0.50, 1.57)  
Total (95% CI) 1113  7641  100.0% 1.35 (1.11, 1.63)
Total events 119  726   
Heterogeneity: Ch2 = 7.07, df = 3 (p =0.07); I2 = 58%    0.1   0.2   0.5 2   5   10
Test for overall effect: Z = 3.06 (p = 0.002)     Experimental Control
        
 
2.2 Premature rupture of membrans
               Experimental  Control  Risk ratio  Risk ratio 
Study Events Total Events Total Weight M-H, fixed, 95% CI           M-H, fixed, 95% CI
Blas et al.13 49 839 130 3378 27.1% 1.50 (1.09, 2.06)
Gravett et al.28 11 47 54 487 0.0% 2.11 (1.94, 3.75)  
Harrison et al.32 4 39 50 447 4.2% 0.92 (0.35, 2.41)  
Kovacs et al.33 70 352 1162 5809 68.8% 0.99 (0.80, 1.23)  
Yu et al.36 10 33 33 267 0.0% 2.45 (1.33, 4.50)  
Total (95% CI) 1240  9634  100.0% 1.13 (0.95, 1.34)  
Total events 123  1342   
Heterogeneity: Ch2 = 7.07; df = 3 (p = 0.07); I2 = 56%    0.01   0.1  10   100
Test for overall effect: Z = 1.34 (p = 0.18)     Experimental Control
       
 
2.3 Low birth weigh
               Experimental  Control  Risk ratio  Risk ratio 
Study Events Total Events Total Weight M-H, fixed, 95% CI           M-H, fixed, 95% CI
Berman et al.31 11 149 37 2123 25.3% 1.34 (0.70, 2.57)
Blas et al.13 40 848 114 2972 48.2% 1.41 (0.99, 2.00)  
Gravett et al.28 15 47 73 535 0.0% 2.12 (1.33, 3.38)  
Harrison et al.32 4 39 51 558 10.6% 1.03 (0.39, 2.79)  
Jain et al.29 6 21 1 38 0.6% 10.86 (1.40, 84.24)  
Kovacs et al.33 24 359 303 5802 30.0% 1.28 (0.86, 1.91)  
Martin et al.30 5 18 19 238 2.3% 3.48 (1.47, 8.23)  
Total (95% CI) 1481  11141  100.0% 1.52 (1.24, 1.87)  
Total events 105  598   
Heterogeneity: Ch2 = 10.69; df = 6 (p = 0.10); I2 = 44%z   0.01   0.1  10   100
Test for overall effect: Z = 3.06 (p < 0.0001)    Experimental Control 
       
cont.
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Table 2. Summary estimates of selected studies for association between Chlamydia infection and perinatal  
morbidity, according to the outcomes (Cont.)
2.4 Perinatal mortality
               Experimental  Control  Risk ratio  Risk ratio 
Study Events Total Events Total Weight M-H, fixed, 95% CI           M-H, fixed, 95% CI
Blas et al.13 7 851 15 3304 28.0% 1.87 (0.76, 4.56)
Harrison et al.32 0 37 3 430 2.6% 1.62 (0.09, 30.79)  
Jain et al.29 3 21 0 39 1.7%  12.73 (0.69, 235.31)  
Kovacs et al.33 13 349 118 5799 62.6% 1.83 (1.04, 3.21)  
Martin et al.30 6 18 8 246 5.1% 10.25 (3.99, 26.35)  
Total (95% CI) 1276  9918  100.0% 2.44 (1.63, 3.68)  
Total events 29  144   
Heterogeneity: Ch2 = 11.52; df = 4 (p = 0.02); I2 = 65%   0.01   01  10   100
Test for overall effect: Z = 4.29 (p < 0.0001)    Experimental Control 
        
 
 
2.5 Endometritis
              Experimental  Control  Risk ratio  Risk ratio 
Study Events Total Events Total Weight M-H, fixed, 95% CI           M-H, fixed, 95% CI
Berman et al.31 11 229 30 800 76.9% 1.28 (0.65, 2.52)
Harrison et al.32 2 76 25 869 23.1% 0.91 (0.22, 3.79)  
Total (95% CI) 305  1669  100.0% 1.20 (0.65, 2.20)  
Total events 13  55   
Heterogeneity: Ch2 = 0.18; df = 1 (p = 0.67); I2 = 0%    0.01   0.1  10   100
Test for overall effect: Z = 0.58 (p = 0.56)     Experimental Control 
        
 
 
2.6 Abortion
                Experimental  Control  Risk ratio  Risk ratio 
Study Events Total Events Total Weight M-H, fixed, 95% CI          M-H, fixed, 95% CI
Harrison et al.32 3 32 21 353 17.2% 1.58 (0.50, 5.00)
Kirk et al.17 5 16 235 782 46.3% 1.04 (0.50, 2.17)  
Martin et al.30 0 18 12 259 8.4% 0.55 (0.03, 8.89)  
Oakeshott et al.34 1 29 120 1185 28.2% 0.34 (0.05, 2.35)  
Total (95% CI) 95  2579  100.0% 0.89 (0.49, 1.61)  
Total events 9  388   
Heterogeneity: Ch2 = 2.17; df = 3 (p = 0.54); I2 = 0%    0.01   0.1  10   100 
Test for overall effect: Z = 0.37 (p = 0.17)     Experimental Control
Silva, Florêncio, Gabiatti, et al.
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Figure 1: Process used in the selection of articles from the search to the quality assessment.
2695 articles identified in electronic databases and manual search
145 articles with full text assessment
68 articles with full text assessment
Loss =1 56 excluded articles (not meet the selection criteria)
12 articles
2550 articles excluded after assessment of titles and abstracts
77 excluded articles (not present adequate study design – cohort or case control)
being said, the effectiveness of treatment during pregnan-
cy is 97% (92.9-99.2) using azithromycin, 95% (76.2-99.9) 
with amoxicillin and 64% (44.1-81.4) with erythromycin. 
Such antibiotics are considered safe for use during the 
prenatal period.38
Pregnant women with CT infection also increased 
the risk of low birth weight, RR = 1.52 [1.24, 1.87]. All 
items involved in this review demonstrated an increased 
risk of CT infection during pregnancy, a fact statistically 
reinforced after the effect of the summary measure. De-
spite the fact that low birth weight may be brought about 
by several other causes, this data suggest that early di-
agnosis and treatment of CT infection during pregnancy 
can minimize the occurrence.13,29,30,32,33 However, even 
with appropriate treatment, 10-20% of infections persist 
or recur during the prenatal period, contributing to the 
emergence of adverse events in pregnancy even with ap-
propriate treatment. Thus, follow-up tests may be needed 
to monitor infection.37
The rate of perinatal mortality, defined as a death 
from 20 weeks gestation until 28 days after birth, was 
significantly higher in pregnant women with CT infec-
tion, with a risk of 1.84 [1.15, 2.94]. All articles showed 
increased risk, which supported the statistical signifi-
cance after the summary measure and analysis of het-
erogeneity.13,29,30,32,33
With regard to abortion and endometritis associated 
with CT, summary measure did not show significant in-
creased risk. Few papers have studied these factors and 
have shown opposing results. CT infection is highly 
prevalent among pregnant women. It can be assumed that 
studies with high methodological quality associated CT 
infection with an increased risk of prematurity, low birth 
weight and perinatal mortality. The publication of new 
studies could possibly strengthen the link being suggest-
ed in current studies. The significance of screening for 
this infection in pregnant women should be considered, 
especially when dealing with younger populations and 
risk factors for STDs. Thus, randomized clinical trials in 
treatment of CT infection in pregnant women are needed 
to evaluate the possibility of reducing this risk.
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